Search results for "postoperative hemorrhage"

showing 10 items of 21 documents

Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation

2013

Introduction. Combined liver-kidney transplantation (LKT) is the best therapeutic option for patients with end-stage liver and kidney disease. Objectives. To analyze baseline characteristics and clinical outcome of LKT compared to isolated liver transplantation (LT). Material and methods. The study included 16 LKT performed between 1998 and 2006 and 32 LT matched by age, sex, date and indication for transplantation. Demographic, pretransplant, post-transplant and survival variables were analyzed. Results. As planned by the study design, mean age, distribution by sex and indication for LT were similar between groups. The most common indication for LT was HCV- and/or alcohol-induced cirrhosis…

Graft RejectionMaleTime FactorsCirrhosismedicine.medical_treatmentSpecialties of internal medicineKaplan-Meier EstimateLiver transplantationGastroenterologyKidney transplantationchemistry.chemical_compoundMetabolic complicationsRisk FactorsKidney transplantationOutcomeBacterial InfectionsGeneral MedicineMiddle AgedSurvival RateTreatment OutcomeRC581-951CreatinineHepatocellular carcinomaHypertensionFemaleAdultReoperationmedicine.medical_specialtyAdolescentPostoperative HemorrhageEnd Stage Liver DiseaseRenal DialysisDiabetes mellitusInternal medicinemedicineHumansArterial PressureDialysisAgedCreatinineChi-Square DistributionLiver transplantationHepatologyurogenital systembusiness.industrymedicine.diseaseSurgeryTransplantationchemistryCase-Control StudiesKidney Failure ChronicbusinessBiomarkers
researchProduct

Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.

2016

Abstract Patients with cirrhosis present with hemostatic alterations secondary to reduced availability of pro-coagulant and anti-coagulant factors. The net effect of these changes is a rebalanced hemostatic system. The Italian Association of the Study of the Liver (AISF) and the Italian Society of Internal Medicine (SIMI) promoted a consensus conference on the hemostatic balance in patients with cirrhosis. The consensus process started with the review of the literature by a scientific board of experts and ended with a formal consensus meeting in Rome in December 2014. The statements were graded according to quality of evidence and strength of recommendations, and approved by an independent …

Liver CirrhosisCirrhosisBleeding; Cirrhosis; Hemostasis; Thrombosis; Hepatology; GastroenterologySettore MED/09 - Medicina InternaBleeding; Cirrhosis; Hemostasis; Thrombosis; Anticoagulants; Coagulants; Drug Monitoring; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Postoperative Hemorrhage; Thrombosis; Blood Coagulation Tests; Hemostasis; Hepatology; Gastroenterology0302 clinical medicineEsophageal and Gastric VariceBlood coagulation testConsensus conferenceGastroenterologyThrombosisOptimal managementCirrhosisCoagulant030220 oncology & carcinogenesisThrombosi030211 gastroenterology & hepatologyBlood Coagulation TestsDrug MonitoringGastrointestinal HemorrhageHumanmedicine.medical_specialtyLiver CirrhosiBleeding; Cirrhosis; Hemostasis; Thrombosis; Gastroenterology; HepatologyPostoperative HemorrhageEsophageal and Gastric VaricesNO03 medical and health sciencesInternal medicinemedicineHumansIn patientIntensive care medicineHemostasisCirrhosiHepatologybusiness.industryCoagulantsBleeding; Cirrhosis; Hemostasis; ThrombosisBleedingAnticoagulantAnticoagulantsThrombosisHepatologyHemostasiBlood Coagulation Testmedicine.diseaseSurgeryHemostasisbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

The use of haemostatic agents in thyroid surgery: efficacy and further advantages. Collagen-Fibrinogen-Thrombin Patch (CFTP) versus Cellulose Gauze.

2013

Abstract Aim: To assess the efficacy of two widely used topical haemostatic agents: oxidised regenerated cellulose gauze and Collagen-Fibrinogen-Thrombin Patch in patients undergoing total thyroidectomy. Material of study: This was a prospective, comparative, non-randomised study in which consecutive patients undergoing total thyroidectomy for benign disease received standard treatment with no haemostatic agent, cellulose gauze, or CFTP. Main outcome measures were drainage volume 24 hours after surgical procedure and the occurrence of post-operative complications (haematoma, seroma, surgical-site infection). Results: Two hundred seventy-one (271) patients undergoing total thyroidectomy for …

MaleSurgical haemostasiThrombinFibrinogenMiddle AgedPostoperative HemorrhageSettore MED/42 - Igiene Generale E ApplicataSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheBandagesHemostasis SurgicalHemostaticsSettore MED/18 - Chirurgia GeneraleThyroidectomyHumansFemaleCollagenProspective StudiesCellulose
researchProduct

Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study

2020

International audience; Purpose To compare the risk of haemorrhagic complications in elective macular surgery between patients with no antithrombotic (AT) treatment (defined as patients with no history of AT therapy or who discontinued AT therapy) and patients who continued AT treatment during the surgery. Methods E-case report forms were prospectively recorded in a database before vitreoretinal surgery and 1 month after. Data on patient characteristics, surgical techniques, haemorrhagic complications and antithrombotic status were collected. Patients with retinal detachment, proliferative diabetic retinopathy and previous retinal haemorrhage were excluded. Results A total of 748 procedures…

Male[SDV]Life Sciences [q-bio]030204 cardiovascular system & hematologynoncardiac surgeryantiplateletsurgery0302 clinical medicineRisk FactorsAntithromboticMedicineProspective Studiesoral anticoagulantsguidelinesantithrombotic agenteducation.field_of_studyAnticoagulantvitreoretinalRetinal HemorrhageGeneral MedicineDiabetic retinopathy3. Good healthPopulation SurveillanceFemalemacular surgeryhaemorrhagehemorrhagemanagementmedicine.medical_specialtymedicine.drug_classPopulationPostoperative Hemorrhagemaintenance03 medical and health sciencesHumans[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrganseducationAgedbusiness.industryanticoagulantAnticoagulantsPerioperativeOdds ratioRetinal Perforationsmedicine.diseasedual antiplatelet therapyvitreoretinal surgeryConfidence intervalSurgerywarfarinOphthalmology030221 ophthalmology & optometrybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyFollow-Up StudiesRetinal haemorrhage
researchProduct

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report.

2006

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report. Pirrello R, Siragusa S, Giambona C, D'Arpa S, Cordova A, Moschella F. Source Dipartimento di Discipline Chirurgiche ed Oncologiche, Sezione di Chirurgia Plastica e Ricostruttiva, Università di Palermo, Palermo, Italy. Abstract The association between factor VII deficiency and cleft palate has never been described. The case of a child with cleft palate and factor VII deficiency who successfully underwent palatoplasty is described in this article. To allow surgical treatment, through maintenance of a normal prothrombin time, the patient was given 15 microg/kg of recombinant factor VIIa every 12 hours, …

Malemedicine.medical_specialtymedicine.medical_treatmentFactor VII DeficiencyPremedicationBlood Loss SurgicalFactor VIIaPostoperative HemorrhageEfficacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMedicineHumans030223 otorhinolaryngologyFactor VII deficiencyProthrombin timemedicine.diagnostic_testFactor VIIbiologybusiness.industryCoagulantsPalate030206 dentistryPerioperativePlastic Surgery ProceduresRecombinant ProteinsSurgeryCleft PalatePalatoplastyEl NiñochemistryOtorhinolaryngologyRecombinant factor VIIaAnesthesiaChild Preschoolbiology.proteinFACTOR VII DEFICIENCY CLEFT PALATE BLEEDING PROPHYLAXISProthrombin TimeOral SurgerybusinessThe Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
researchProduct

Delayed Suprachoroidal Hemorrhage After Pars Plana Vitrectomy: Five-Year Results of a Retrospective Multicenter Cohort Study

2015

Purpose To determine the incidence, risk factors, and outcomes of delayed suprachoroidal hemorrhage after vitrectomy. Design Retrospective multicenter cohort study. Methods All consecutive patients who underwent primary vitrectomy, from January 2009 to December 2014, at 4 tertiary vitreoretinal centers in Italy were enrolled. Patient demographics and systemic, ophthalmic, operative, and postoperative data from all centers were extracted from the electronic record system using standardized data collection forms. All eyes that developed delayed suprachoroidal hemorrhage within 48 hours of the end of the vitrectomy were identified as the delayed suprachoroidal hemorrhage group; all other eyes …

Pars planaChoroid HemorrhageMalemedicine.medical_specialtyTime FactorsTime FactorFundus Oculimedicine.medical_treatmentVitrectomyPostoperative HemorrhageChoroid hemorrhageFollow-Up StudieRetrospective StudieRisk FactorsOphthalmologyVitrectomymedicineHumansFluorescein AngiographyAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryRisk FactorRetinal DetachmentRetinal detachmentRetrospective cohort studyOdds ratioMiddle AgedFluorescein angiographymedicine.diseaseSurgeryOphthalmologymedicine.anatomical_structureFemalebusinessHumanCohort studyFollow-Up Studies
researchProduct

Safety of aprotinin in adult cardiac surgery: revisiting the validity of a mixed-treatment comparison meta-analysis.

2013

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryTreatment comparisonBlood Loss SurgicalPostoperative HemorrhageAntifibrinolytic AgentsCardiac surgeryAprotininMeta-analysisAnesthesiaAntifibrinolytic agentmedicineHumansSurgeryAprotininCardiology and Cardiovascular MedicinebusinessIntensive care medicinemedicine.drugThe Journal of thoracic and cardiovascular surgery
researchProduct

Immediate bleeding complications in dental implants: A systematic review

2014

Objective: A review is made of the immediate or immediate postoperative bleeding complications in dental implants, with a view to identifying the areas of greatest bleeding risk, the causes of bleeding, the length of the implants associated with bleeding, the most frequently implicated blood vessels, and the treatments used to resolve these complications. Material and Methods: A Medline (PubMed) and Embase search was made of articles on immediate bleeding complications in dental implants published in English up until May 2014. Inclusion criteria: studies in humans subjects with severe bleeding immediately secondary to implant placement, which reported the time until the hemorrhage, the impl…

Severe bleedingmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPerforation (oil well)DentistryOdontologíaReviewPostoperative HemorrhageAnticoagulation TreatmentMandibular caninemedicineIntubationHumansGeneral DentistryDental Implantsbusiness.industry:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryImplant placementOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryImplantOral SurgerybusinessAirwayMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Tranexamic acid in cardiac surgery: Are low doses enough?

2020

OBJECTIVES Tranexamic acid is used to prevent hyperfibrinolysis and reduce postoperative bleeding and blood transfusions in on-pump cardiac surgery. We evaluate the efficacy of low or high dose tranexamic acid in a prospective cohort study conducted in Valencia. MATERIALS AND METHODS A total of 427 patients were recruited between January 2019 and January 2020, 207 in the Hospital General Universitario (low dose [LD]) and 220 in the Hospital Universitario y Politecnico La Fe (high dose [HD] and intermediate dose [ID]). We recorded the presence of hyperfibrinolysis on rotational thromboelastometry, intra- and postoperative administration of blood products, chest tube output within the first 1…

Univariate analysismedicine.medical_specialtybusiness.industrymedicine.medical_treatmentGeneral MedicinePostoperative Hemorrhagemedicine.diseaseHyperfibrinolysisAntifibrinolytic AgentsCardiac surgeryThromboelastometryTranexamic AcidAnesthesiaFibrinolysismedicineHumansFresh frozen plasmaProspective StudiesCardiac Surgical ProceduresbusinessProspective cohort studyTranexamic acidmedicine.drugRevista espanola de anestesiologia y reanimacion
researchProduct

Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature.

2015

Background Dabigatran is a newly commercialized drug that is replacing other anticoagulants in the prevention of venous thromboembolism, stroke and systemic arterial valve embolism. It acts directly on thrombin presenting in a dynamic and predictable way, which does not require monitoring these patients. Therefore, we consider the need to assess whether their use increases the risk of bleeding involved before any dental treatment. Material and Methods We performed a systematic review with a bibliographic search in PubMed/Medline along with the Cochrane Library. We excluded articles dealing with all anticoagulants other than dabigatran, and works about surgical treatments in anatomical locat…

medicine.medical_specialtyOral Surgical ProceduresPsychological interventionMEDLINEAdministration OralReviewCochrane LibraryPostoperative Hemorrhagelaw.inventionDabigatran03 medical and health sciences0302 clinical medicineRandomized controlled triallawMedicineHumansIntensive care medicineGeneral DentistryStrokebusiness.industryAnticoagulants030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistrySurgeryDabigatranClinical trialOtorhinolaryngologyEmbolism030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgerybusinessmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct